Cargando…
Diagnostic value of selected markers and apoptotic pathways for pancreatic cancer
Pancreatic cancer occupies the fourth place as a cause of death from cancer, and the mortality rate is similar to the number of newly detected cases. Due to the late diagnosis, only 5-6% of patients with pancreatic cancer survive for five years. Given that early diagnosis is critical for improving p...
Autores principales: | Słotwiński, Robert, Słotwińska, Sylwia Małgorzata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Polish Society of Experimental and Clinical Immunology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382885/ https://www.ncbi.nlm.nih.gov/pubmed/28450803 http://dx.doi.org/10.5114/ceji.2016.65139 |
Ejemplares similares
-
Dysregulation of signaling pathways associated with innate antibacterial immunity in patients with pancreatic cancer
por: Słotwiński, Robert, et al.
Publicado: (2017) -
Pancreatic cancer and adaptive metabolism in a nutrient-deficient environment
por: Słotwiński, Robert, et al.
Publicado: (2021) -
MicroRNAs in pancreatic cancer diagnosis and therapy
por: Słotwiński, Robert, et al.
Publicado: (2018) -
Molecular aspects of pancreatic cancer: focus on reprogrammed metabolism in a nutrient-deficient environment and potential therapeutic targets
por: Słotwiński, Robert, et al.
Publicado: (2021) -
Immune disorders in anorexia
por: SŁOTWIŃSKA, SYLWIA MAŁGORZATA, et al.
Publicado: (2017)